BioCentury
ARTICLE | Financial News

GlycoDesign files for IPO

October 2, 2000 7:00 AM UTC

GlycoDesign (Toronto, Ontario), which is developing drugs for cancer, inflammatory and infectious diseases, filed for a Canadian IPO that will be underwritten by Loewen, Ondaatje, McCutcheon; BMO Nesb...